FINNENCE ▪ THE WIRE FILE
THE WIRE · № 77674
News▼ Bearish
Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim
KINDNews
DIRECTION▼ Bearish
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Contempt claim against Shkreli tests enforcement of pharma bans, signaling tighter regulatory scrutiny of drug pricing conduct.
Pharma ban enforcement, sector conduct scrutiny
CATALYST TO WATCH
Court ruling on contempt motion
MAIN RISK
Outcome uncertain; limited direct ticker
FULL DISPATCH
Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim.
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
J&J Medtech Sales Disappoint, Considers Orthopedic Spinoff2026-10-13 13:36 UTC
J&J Medtech Sales Disappoint, Considers Orthopedic Spinoff2026-10-13 13:36 UTC
→CORRELATIONshares Healthcare
IQVIA selecciona las aplicaciones de Veeva Clinical Operations2026-10-13 14:02 UTC
IQVIA selecciona las aplicaciones de Veeva Clinical Operations2026-10-13 14:02 UTC
→CORRELATIONshares Healthcare
Medical Device Cleaning Market worth $3.93 billion by 20312026-10-13 14:30 UTC
Medical Device Cleaning Market worth $3.93 billion by 20312026-10-13 14:30 UTC
→CORRELATIONshares Healthcare
Longevity Health Earns 5-Star CMS Ratings Across Portfolio for Second Consecutive Year2026-10-13 14:30 UTC
Longevity Health Earns 5-Star CMS Ratings Across Portfolio for Second Consecutive Year2026-10-13 14:30 UTC
→CORRELATIONshares Healthcare
Pompe Disease Market Set for Expansion During the Forecast Period (2026-2036) as Growth is Fueled by Next-Generation ERTs, Newborn Screening, and Pipeline Innovation2026-10-13 14:31 UTC
Pompe Disease Market Set for Expansion During the Forecast Period (2026-2036) as Growth is Fueled by Next-Generation ERTs, Newborn Screening, and Pipeline Innovation2026-10-13 14:31 UTC
→CORRELATIONshares Healthcare
EU approves Kimberly-Clark's acquisition of Kenvue, subject to conditions2026-10-13 14:16 UTC
EU approves Kimberly-Clark's acquisition of Kenvue, subject to conditions2026-10-13 14:16 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.